Uncommon side effects of these medications can include pancreatitis, gastroparesis, bowel obstruction, gallstone attacks and bile duct blockages
As many as 20 million people in the US have experienced long Covid, a chronic condition that lasts for at least three months after an initial infection
As we move through 2026, patients should: Stay informed about regulatory developments affecting compounded GLP-1 access Monitor their own experiences carefully and report any serious side effects Maintain open communication with both telehealth providers and primary care doctors Recognize that sustainable weight management involves multiple factors beyond medication alone Plan for financial sustainability of long-term treatment For people who've struggled with obesity and its associated health risks, GLP-1 medications represent an important advancement in medical weight management
The GIP component may also contribute to potentially milder gastrointestinal side effects compared to GLP-1-only medications
Gallbladder disease including cholelithiasis, another class-level concern with GLP-1-based therapies
GLP-1 medications, like Ozempic, Wegovy, and Mounjaro, have various known side effects, including nausea, fatigue, constipation, and diarrhea